Abstract
Purpose: It is well established that patients with early breast cancer undergoing chemotherapy or those with active cancer on treatment are at risk of venous thromboembolic disease (VTE) [1] and recurrent VTE events [2]. In this retrospective analysis, we aimed to ascertain if local guidelines for the treatment of VTE events are effective in patients with metastatic breast cancer, in preventing recurrent VTE events.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical oncology (Royal College of Radiologists (Great Britain))
Paper Title
Journal
Date
